Wave Life Sciences WVE
NASDAQ WVE
$4.85 +0.15 (+3.19%)
As of: Sep 4, 2026 · 3:59 PM EDT

Wave Life Sciences (WVE) Prepaid Assets (2014 - 2026)

Wave Life Sciences' (WVE) quarterly Prepaid Assets came in at $12.1 million in Q2 2026, up 79.36% YoY from $6.8 million in Q2 2025, and down 8.35% on a QoQ basis from $13.2 million in Q1 2026.

Analysis

Wave Life Sciences (WVE) Prepaid Assets (2014 - 2026) Analysis & Trends

Wave Life Sciences (WVE) has 13 years of Prepaid Assets data on file, last reported at $12.1 million in Q2 2026.

  • Quarterly Prepaid Assets rose 79.36% year-over-year to $12.1 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $12.1 million (up 79.36% YoY) and the FY2025 annual result came in at $8.4 million, down 12.04% from the prior year.
  • Prepaid Assets retreated to $12.1 million in Q2 2026, from $13.2 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $13.2 million in Q1 2026 to a low of $6.6 million in Q2 2022.
  • A 5-year average of $9.1 million and a median of $8.7 million in 2023 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2025 — Prepaid Assets tumbled 44.36% — and 2026, when it soared 79.36%.
  • Tracing WVE's Prepaid Assets over 5 years: stood at $7.9 million in 2022, then grew by 24.96% to $9.9 million in 2023, then slipped by 3.71% to $9.5 million in 2024, then fell by 12.04% to $8.4 million in 2025, then soared by 44.38% to $12.1 million in 2026.
  • The last three Prepaid Assets figures came in at $12.1 million (Q2 2026), $13.2 million (Q1 2026), and $8.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Wave Life Sciences 994.54 Mn 626.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.12 Mn
Mar 31, 2026 13.23 Mn
Dec 31, 2025 8.40 Mn
Sep 30, 2025 6.65 Mn
Jun 30, 2025 6.76 Mn
Mar 31, 2025 8.06 Mn
Dec 31, 2024 9.54 Mn
Sep 30, 2024 10.57 Mn
Jun 30, 2024 12.15 Mn
Mar 31, 2024 11.14 Mn
Dec 31, 2023 9.91 Mn
Sep 30, 2023 7.51 Mn
Jun 30, 2023 9.01 Mn
Mar 31, 2023 9.23 Mn
Dec 31, 2022 7.93 Mn
Sep 30, 2022 7.42 Mn
Jun 30, 2022 6.56 Mn
Mar 31, 2022 6.94 Mn
Dec 31, 2021 6.58 Mn
Sep 30, 2021 7.63 Mn